Can We Justify Intralesional Immunotherapy with Measles-mumps-rubella Vaccine for Recalcitrant Facial Warts?

Oman Med J. 2022 Nov 30;37(6):e451. doi: 10.5001/omj.2022.97. eCollection 2022 Nov.

Author

Mahmood Dhahir Al-Mendalawi¹

Affiliation

¹ Department of Pediatrics, Al-Kindy College of Medicine, University of Baghdad, Baghdad, Iraq.

No abstract available

Publication types

Editorial